• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞特异性分子-1作为垂体无功能细胞腺瘤侵袭性的标志物。

Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma.

机构信息

Department of Neurosurgery, Fuzhou 900 Hospital, Fujian Medical University, No.156 Xihuanbei Road, Fuzhou, 350025, People's Republic of China.

Department of Neurosurgery, Fujian provincial Hospital, Chinese People's Armed Police Forces, Fuzhou, 350025, People's Republic of China.

出版信息

BMC Endocr Disord. 2019 Aug 27;19(1):90. doi: 10.1186/s12902-019-0418-8.

DOI:10.1186/s12902-019-0418-8
PMID:31455321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712719/
Abstract

BACKGROUND

Endothelial cell-specific molecule-1 (ESM-1) is a biomarker associated with tumor progression in pituitary adenoma. We specifically focused on one type of pituitary adenoma, namely null cell adenoma (NCA) and evaluated the relationship between invasion and ESM-1 expression in both vascular endothelial and adenoma tissues.

METHODS

Tissue samples from 94 patients with pituitary NCA were obtained through microscopic transsphenoidal resection. Tumor size and invasion were determined through preoperative magnetic resonance imaging. Immunohistochemical staining was performed to detect ESM-1 expression. ESM-1 index of ≥3 was defined as high expression.

RESULTS

Signs of invasion were observed in 46 (47.9%) of the 94 patients. Significant differences were observed in the invasion state and maximum tumor diameter between high and low expression of ESM-1 in vascular endothelial tissues (both P < 0.05). Significant positive associations were noted between ESM-1 expression in vascular endothelial tissues and tumor invasion (P = 0.002) and tumor size (P = 0.020). However, only tumor size was associated with ESM-1 expression in adenoma tissues (P = 0.016).

CONCLUSION

In NCA, a significant positive association between tumor invasion and ESM-1 expression was observed only in vascular endothelial tissues, suggesting that tumor progression occurs mainly through ESM-1-associated mechanism.

摘要

背景

内皮细胞特异性分子-1(ESM-1)是与垂体腺瘤肿瘤进展相关的生物标志物。我们特别关注一种垂体腺瘤,即无功能细胞腺瘤(NCA),并评估了血管内皮和腺瘤组织中侵袭与 ESM-1 表达之间的关系。

方法

通过显微镜经蝶窦切除术获得 94 例 NCA 患者的组织样本。通过术前磁共振成像确定肿瘤大小和侵袭程度。进行免疫组织化学染色以检测 ESM-1 表达。ESM-1 指数≥3 定义为高表达。

结果

在 94 例患者中,有 46 例(47.9%)存在侵袭迹象。在血管内皮组织中,ESM-1 的高表达与低表达之间,侵袭状态和最大肿瘤直径存在显著差异(均 P<0.05)。血管内皮组织中 ESM-1 的表达与肿瘤侵袭(P=0.002)和肿瘤大小(P=0.020)呈显著正相关。然而,只有在腺瘤组织中,肿瘤大小与 ESM-1 的表达相关(P=0.016)。

结论

在 NCA 中,仅在血管内皮组织中观察到肿瘤侵袭与 ESM-1 表达之间存在显著正相关,这表明肿瘤进展主要通过 ESM-1 相关机制发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c7d/6712719/8eaf8e0cd6a3/12902_2019_418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c7d/6712719/8eaf8e0cd6a3/12902_2019_418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c7d/6712719/8eaf8e0cd6a3/12902_2019_418_Fig1_HTML.jpg

相似文献

1
Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma.内皮细胞特异性分子-1作为垂体无功能细胞腺瘤侵袭性的标志物。
BMC Endocr Disord. 2019 Aug 27;19(1):90. doi: 10.1186/s12902-019-0418-8.
2
A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.内皮抑素(ESM-1)与血管内皮细胞标志物(CD34/CD105)在垂体腺瘤侵袭中的表达比较分析
Pituitary. 2016 Apr;19(2):194-201. doi: 10.1007/s11102-015-0698-6.
3
Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.长链非编码 RNA C5orf66-AS1 在垂体嫌色细胞瘤中下调,与它们的侵袭性有关。
Oncol Rep. 2017 Aug;38(2):1140-1148. doi: 10.3892/or.2017.5739. Epub 2017 Jun 22.
4
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.354例接受经蝶窦手术治疗的垂体腺瘤患者中显微镜下硬脑膜侵犯的长期意义。
J Neurosurg. 2002 Feb;96(2):195-208. doi: 10.3171/jns.2002.96.2.0195.
5
Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.垂体无细胞腺瘤:对其临床影像学和行为特征的机构性回顾。
Endocr Pathol. 2015 Mar;26(1):63-70. doi: 10.1007/s12022-014-9347-2.
6
[Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].[内皮抑素-1在肝细胞癌中的表达与血管生成和肿瘤侵袭相关]
Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):661-4.
7
Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers.使用放射学、手术、临床和组织病理学标志物评估垂体腺瘤的侵袭性行为和侵袭特征
Turk Neurosurg. 2016;26(5):671-7. doi: 10.5137/1019-5149.JTN.13161-14.2.
8
Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features.缺氧诱导因子-1α调控内皮细胞特异性分子-1 在人结肠癌中的表达:ESM-1 对预后的影响及其与临床病理特征的相关性。
Oncol Rep. 2012 Nov;28(5):1701-8. doi: 10.3892/or.2012.2012. Epub 2012 Sep 3.
9
The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.垂体腺瘤侵袭性与通过拓扑异构酶IIα免疫表达测量的增殖指数之间的关系。
Endokrynol Pol. 2018;69(5):530-535. doi: 10.5603/EP.a2018.0050. Epub 2018 Aug 3.
10
Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma.内皮细胞中内皮蛋白聚糖的表达与垂体腺瘤的肿瘤进展密切相关。
Brain Pathol. 2012 Nov;22(6):757-64. doi: 10.1111/j.1750-3639.2012.00578.x. Epub 2012 Mar 16.

引用本文的文献

1
Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.垂体肿瘤的预后生物标志物:一项系统综述
touchREV Endocrinol. 2023 Nov;19(2):42-53. doi: 10.17925/EE.2023.19.2.12. Epub 2023 Aug 9.
2
Crosstalk between Endothelial Cells and Tumor Cells: A New Era in Prostate Cancer Progression.内皮细胞与肿瘤细胞的串扰:前列腺癌进展的新时代。
Int J Mol Sci. 2023 Nov 29;24(23):16893. doi: 10.3390/ijms242316893.
3
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.侵袭性 PitNETs 及潜在的靶向治疗:分子和遗传途径的系统综述。

本文引用的文献

1
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.2017 年世界卫生组织垂体瘤分类:概述。
Acta Neuropathol. 2017 Oct;134(4):521-535. doi: 10.1007/s00401-017-1769-8. Epub 2017 Aug 18.
2
The Likelihood of Remnant Nonfunctioning Pituitary Adenomas Shrinking Is Associated with the Lesion's Blood Supply Pattern.残余无功能垂体腺瘤缩小的可能性与病变的血供模式相关。
World Neurosurg. 2017 Nov;107:137-141. doi: 10.1016/j.wneu.2017.07.141. Epub 2017 Aug 2.
3
A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719.
4
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy.肿瘤微环境在垂体神经内分泌肿瘤中的作用:分类、诊断和治疗的新方法
Cancers (Basel). 2023 Nov 6;15(21):5301. doi: 10.3390/cancers15215301.
5
Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness.无功能垂体腺瘤中的细胞增殖、凋亡及血管生成:与肿瘤侵袭性的关联
Endocrine. 2020 Sep;69(3):596-603. doi: 10.1007/s12020-020-02366-6. Epub 2020 Jul 12.
6
CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.CCNB1 通过上皮间质转化影响垂体腺瘤的海绵窦侵袭。
J Transl Med. 2019 Oct 4;17(1):336. doi: 10.1186/s12967-019-2088-8.
内皮抑素(ESM-1)与血管内皮细胞标志物(CD34/CD105)在垂体腺瘤侵袭中的表达比较分析
Pituitary. 2016 Apr;19(2):194-201. doi: 10.1007/s11102-015-0698-6.
4
Endocan, a new invasion and angiogenesis marker of pituitary adenomas.内皮抑素,一种垂体腺瘤新的侵袭和血管生成标志物。
J Neurooncol. 2014 May;117(3):485-91. doi: 10.1007/s11060-014-1377-6. Epub 2014 Feb 7.
5
Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.经蝶窦手术治疗无功能垂体腺瘤后的肿瘤退缩。
J Neurosurg. 2013 Dec;119(6):1447-52. doi: 10.3171/2013.8.JNS13790. Epub 2013 Sep 27.
6
Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre.垂体的微血管形态计量学与垂体瘤:从实验室到手术室。
Microvasc Res. 2013 Sep;89:7-14. doi: 10.1016/j.mvr.2013.04.009. Epub 2013 May 4.
7
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.内皮细胞蛋白在浸润性膀胱癌的肿瘤血管中上调,在那里它介导 VEGF-A 诱导的血管生成。
Cancer Res. 2013 Feb 1;73(3):1097-106. doi: 10.1158/0008-5472.CAN-12-1855. Epub 2012 Dec 14.
8
Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence.垂体腺瘤中血管内皮生长因子的过度表达与鞍外生长和复发有关。
Pituitary. 2013 Sep;16(3):370-7. doi: 10.1007/s11102-012-0434-4.
9
Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma.内皮细胞中内皮蛋白聚糖的表达与垂体腺瘤的肿瘤进展密切相关。
Brain Pathol. 2012 Nov;22(6):757-64. doi: 10.1111/j.1750-3639.2012.00578.x. Epub 2012 Mar 16.
10
Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion.内皮抑素基因在肝细胞癌内皮细胞中的过表达与血管生成和肿瘤侵袭相关。
J Int Med Res. 2010 Mar-Apr;38(2):498-510. doi: 10.1177/147323001003800213.